Release Date: 31/07/09 10:07 Summary: Share Placement Closes Oversubscribed Price Sensitive: Yes Download Document 255.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%